TARGANTA THERAPEUTICS
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.
TARGANTA THERAPEUTICS
Industry:
Biopharma Health Care Pharmaceutical
Founded:
2005-12-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.targanta.com
Total Employee:
51+
Status:
Active
Contact:
973 290 6000
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Google Maps LetsEncrypt SSL By Default IPv6 Cloudflare Hosting Cloudflare CDN Cloudflare Cloudflare DNS Cloudflare Network Error Logging Clicky
Stock Details
Investors List
Seaflower Ventures
Seaflower Ventures investment in Series C - Targanta Therapeutics
OrbiMed
OrbiMed investment in Series C - Targanta Therapeutics
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Series C - Targanta Therapeutics
Brookside Capital
Brookside Capital investment in Series C - Targanta Therapeutics
Skyline Ventures
Skyline Ventures investment in Series C - Targanta Therapeutics
Radius Ventures
Radius Ventures investment in Series C - Targanta Therapeutics
Official Site Inspections
http://www.targanta.com
- Host name: 104.21.32.1
- IP address: 104.21.32.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Targanta Therapeutics"
Targanta Therapeutics - Corporate Overview
Targanta, Inc. is a biopharmaceutical company focused on developing and commercializing antibacterial agents. Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic …See details»
Targanta Therapeutics - Corporate Mission
Homepage About Us. Corporate Mission; Corporate Overview; Compliance Program; Code of Conduct; Pipeline News People Careers Contact Us : Corporate Mission Targanta …See details»
Targanta Therapeutics Corporation - Wikipedia
Targanta Therapeutics Corporation was a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company also had operations in Indianapolis, Montreal and Toronto. Targanta completed its initial public offering on October 9, 2007 and traded on the Nasdaq market under the symbol: TARG. Targanta was acquired by The Medicines Company in 2009. See details»
Targanta Therapeutics - Crunchbase Company Profile …
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious …See details»
Organization | Targanta
Targanta Report issue. Contributed to NME For profit Phase 2. Founded: Cambridge MA United States (1997) Status: Acquired by The Medicines Company (2009 ...See details»
Targanta Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Targanta Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 9 literature.See details»
Targanta Therapeutics - Overview, News & Similar companies
Jul 18, 2022 Who is Targanta Therapeutics. Targanta Therapeutics Corporation is a biopharmaceutical company focused on developing and commercializing innovative antibiotics …See details»
Targanta Therapeutics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Targanta Therapeutics Corporation of Morristown, NJ. Get the latest business insights from Dun & …See details»
Targanta Therapeutics Corp. - Drug pipelines, Patents, Clinical …
Explore Targanta Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 9 news, and 9 literature, Disease Domain:Infectious Diseases, Technology …See details»
Our Company | The Medicines Company - Targanta
Jan 3, 2018 Contact us. The Medicines Company 8 Sylvan Way Parsippany, NJ 07054 USA. Tel 973 290 6000 Toll-free 800 388 1183 Fax 973 656 9898See details»
Targanta Therapeutics - Contacts, Employees, Board Members
Targanta Therapeutics is a biopharma Company. Unlock even more features with Crunchbase ProSee details»
Targanta Therapeutics - Funding, Financials, Valuation & Investors
Targanta Therapeutics is registered under the ticker NASDAQ:TARG . Their stock opened with $10.00 in its Oct 10, 2007 IPO. Stock Symbol NASDAQ:TARG ; Money Raised at IPO $57.5M; …See details»
Targanta Therapeutics: Hitting a Moving Target - The Case Centre
Jul 17, 2009 This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In …See details»
Targanta Therapeutics Corporation - Wikidata
Targanta Therapeutics Corporation (Q7685835) From Wikidata. Jump to navigation Jump to search. No description defined. edit. Language Label Description Also known as; English: …See details»
What is Targanta? Company Culture, Mission, Values
See what employees say it's like to work at Targanta. Salaries, reviews, and more - all posted by employees working at Targanta.See details»
Targanta Therapeutics - Corporate Overview
Targanta's latest-stage antibacterial drug, oritavancin, is a semisynthetic glycopeptide with potent bactericidal activity against nearly all clinically relevant, difficult-to-treat Gram-positive …See details»
Targanta Therapeutics - Corporate Mission
Targanta Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibacterial agents to address unmet medical needs in the hospital …See details»
Working at Targanta - Glassdoor
Targanta Therapeutics' mission is to build a better antibiotic. The biopharmaceutical company is developing new treatments for severe, drug-resistant bacterial infections, including those that …See details»